Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids? - Wikidata - awgldk - TriplyDB

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

http://www.wikidata.org/entity/Q38571581

about

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease

P2860

Q36141290-A4071146-899C-40E8-87F6-E998A62EFB08 Q58765841-67E3A0A4-18CC-4E56-926F-9F5B96B4C4ED

P2860

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

http://www.wikidata.org/entity/Q38571581

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

@en

type

label

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

@en

prefLabel

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

@en

P1433

Q38571581-B47A354E-080F-4287-80D5-5BE8AE20E908

P1476

Q38571581-126F1288-952F-4924-AEB5-E38E97F4A87C

P2093

Q38571581-4486C38F-E551-4DF6-A56C-06A5AFAD6F70

Q38571581-7AA78826-7B3E-46D2-88A9-E3D3EC580F69

Q38571581-82267816-2957-491B-98AF-0112D096D008

P2860

Q38571581-036694C6-DF68-43B5-BC40-81BDB300DF9D

Q38571581-0886AF6E-3C1D-4F0F-996C-496935324A9D

Q38571581-099EAEBB-E216-4B88-8B2D-B5AC38EFF6F5

Q38571581-0D0DA883-FE5B-4F05-AF4F-F47E9BE8EA44

Q38571581-121C3875-CCE2-4BDB-A844-B400BE7ECBAB

Q38571581-189072E8-64C9-4C67-88C5-5EB0205FD8F3

Q38571581-1D772110-DC5F-4682-BAE7-6D6B65DE4729

Q38571581-2CE0787C-3E5D-45DA-9A66-4AF47B4B16D6

Q38571581-2ECADCF2-FAAB-49A0-9C77-162C5214BF25

Q38571581-31AC42C1-9ABB-41C8-8468-EBD3BE98E290

P2888

Q38571581-DE513EEA-DB6F-45C0-9AB1-403D2585B3A6

P304

Q38571581-508D4DCD-58D0-494C-90E5-EC796447B148

P31

Q38571581-A0F7CECC-55FB-4733-A59D-E69C5D0E64D6

P356

Q38571581-10908530-AFC2-4681-8101-22F4BB730F95

P433

Q38571581-D841E181-D4DC-481E-8F8C-B447A293C9C3

P478

Q38571581-58581DC5-91C1-4E01-9878-D9AC1FBBCBF6

P50

Q38571581-024C3FA4-18E6-4E86-91F1-7F4AABD6F39C

P577

Q38571581-91DF91DC-2C8E-4F4E-A2E3-854AE383270F

P698

Q38571581-6412F05E-6DC2-40B3-BBEE-B8B1769A2F58

P356

S40266-015-0291-8

P1433

P1476

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

@en

P2093

Andrea P Rossi

http://www.w3.org/2001/XMLSchema#string

Andrea Rossi

http://www.w3.org/2001/XMLSchema#string

Erika Zanardi

http://www.w3.org/2001/XMLSchema#string

P2860

Indacaterol therapy in patients with COPD not receiving other maintenance treatment

Measuring the global burden of disease

Lung function decline in COPD

Inflamm-aging. An evolutionary perspective on immunosenescence

Interpretative strategies for lung function tests

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

P2888

s40266-015-0291-8

P304

679-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-015-0291-8

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26297533

http://www.w3.org/2001/XMLSchema#string